2022
DOI: 10.1177/02698811221127304
|View full text |Cite
|
Sign up to set email alerts
|

Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes

Abstract: Background: Psychedelics are receiving renewed attention within Western medicine as they represent potential treatments for many difficult-to-treat mental health disorders. However, psychedelic science is limited in its focus and inclusion of racial and ethnic minorities. Hence, this study examines whether race and ethnicity moderate the associations that naturalistic 3,4-methylenedioxymethamphetamine (MDMA)/ecstasy use and psilocybin use share with major depressive episodes (MDEs). Method: Data for this proje… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 66 publications
(83 reference statements)
1
10
1
Order By: Relevance
“…Specifically, this study seeks to expand on Jones and Nock ( 4 ) and test whether race and ethnicity moderates the relationships between lifetime psilocybin use and lowered odds of crime arrests, as this prior work demonstrated associations between lifetime psilocybin use and lowered odds of arrests for various types of crime. In line with Jones and Nock ( 11 ) and Jones ( 12 ), we hypothesized that there would be fewer and weaker relationships between psychedelic use and crime arrests for participants of color in this sample.…”
Section: Introductionmentioning
confidence: 80%
See 2 more Smart Citations
“…Specifically, this study seeks to expand on Jones and Nock ( 4 ) and test whether race and ethnicity moderates the relationships between lifetime psilocybin use and lowered odds of crime arrests, as this prior work demonstrated associations between lifetime psilocybin use and lowered odds of arrests for various types of crime. In line with Jones and Nock ( 11 ) and Jones ( 12 ), we hypothesized that there would be fewer and weaker relationships between psychedelic use and crime arrests for participants of color in this sample.…”
Section: Introductionmentioning
confidence: 80%
“…The following demographic factors and lifetime use variables served as covariates in our analyses: sex (male or female), age (18–25, 26–34, 35–49, 50 or older), educational attainment (less than high school, some high school or high school graduate, some college or above), self-reported engagement in risky behavior (never, seldom, sometimes, or always), annual household income (less than $20,000, $20,000–$49,999, $50,000–$74,999, $75,000 or more), marital status (married, divorced/separated, widowed, or never married), survey year (2002–2020), and lifetime use of various substances [MDMA/ecstasy, other classic psychedelics (LSD, peyote, and mescaline), other illegal substances (cocaine, heroin, PCP, inhalants) and other commonly misused legal/medicinal substances (pain relievers, tranquilizers, stimulants, sedatives, and marijuana)]. These exact covariates have been used in prior population-based survey studies investigating race, psychedelic use, and deleterious outcomes ( 11 , 12 ).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…National data has shown that psilocybin and MDMA use was linked to improved health outcomes for white users. However, there were minimal or no associations observed among users from different racial or ethnic minority groups [ 31 , 32 ]. Another study found that, while those who are employed and use psychedelics have significantly lower levels of psychological distress, non-employed users have higher levels of distress [ 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…A follow-up study suggests racial trauma symptoms may be moderated through an increase in psychological flexibility conferred by psychedelic use (Davis, Xin, et al, 2021). On the other hand, nationally represented data have found that while psilocybin and MDMA use was associated with better health outcomes for White users, there were little to no association among users who were race or ethnic minorities (Jones, 2023; Jones and Nock, 2022b).…”
Section: Introductionmentioning
confidence: 99%